Open access · CC-BY
via OpenAlex
Association of blood cadmium levels with epigenetic age acceleration in U.S. adults aged > 50 years
Panpan Mi, Xu Cao, Haixia Feng, Huijie Wang
Frontiers in Public Health · 2025 · ▲ 6 citations
Abstract
Objectives DNA methylation (DNAm) is a sensitive biomarker of aging-related processes, and novel epigenetic-based “clocks” can estimate accelerated biological aging. Cadmium (Cd) can alter cellular processes that promote aging and disrupt global methylation patterns. However, few studies have investigated the association between blood Cd and accelerated aging. We aimed to investigate the association between blood Cd and four DNAm-based epigenetic age accelerations in individuals over 50 in the United States, using data from the National Health and Nutrition Examination Survey (NHANES). Methods DNAm-epigenetic biomarkers and blood Cd data from the NHANES database (1999–2002) were retrieved for this study. We evaluated four epigenetic ages: HorvathAge, HannumAge, PhenoAge, and GrimAge. Age acceleration was calculated by extracting the residuals from the regression of chronological age on each epigenetic age measure. We used weighted linear regression models and subgroup analyses to investigate the associations between blood Cd levels and these age accelerations, adjusting for potential confounding factors. Results Higher blood Cd levels (≥0.5 μg/dl) were significantly associated with increased age acceleration for PhenoAge (β = 1.37, P = 0.017) and GrimAge (β = 1.31, P = 0.003) in adjusted models. A significant association was also observed for HannumAge (β = 0.94, P = 0.016), although this association was not significant for continuous Cd levels (P = 0.111). No significant associations were found for HorvathAge. Subgroup analyses indicated consistent associations across demographic and lifestyle subgroups, with no significant interactions. Conclusions In this study, after adjusting for confounders, blood Cd levels were positively associated with PhenoAge acceleration and GrimAge acceleration in people over 50 in the United States. These results may be useful in proposing interventions in environmental exposures to slow the aging process and prevent age-related diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fpubh.2025.1504830
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Mi, P., Cao, X., Feng, H., & Wang, H. (2025). Association of blood cadmium levels with epigenetic age acceleration in U.S. adults aged > 50 years. <em>Frontiers in Public Health</em>. https://doi.org/10.3389/fpubh.2025.1504830
Vancouver
Mi P, Cao X, Feng H, Wang H. Association of blood cadmium levels with epigenetic age acceleration in U.S. adults aged > 50 years. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1504830.
BibTeX
@article{panpan2025Associ,
title = {Association of blood cadmium levels with epigenetic age acceleration in U.S. adults aged > 50 years},
author = {Panpan Mi and Xu Cao and Haixia Feng and Huijie Wang},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1504830},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Nutrition 2025
Open access · CC-BY
Non-linear association between serum levels of vitamins A and B12 and accelerated epigenetic aging
The Journals of Gerontology Series A 2024
Open access · OA
High-Impact Pain Is Associated With Epigenetic Aging Among Middle-Aged and Older Adults: Findings From the Health and Retirement Study
Scientific reports 2026
Open access · OA
Longitudinal association of circulating inflammatory biomarkers with epigenetic ageing in the Young Finns Study.
Toxics 2026
Open access · CC-BY
Combined Effect of Per- and Polyfluoroalkyl Substances and Metals on Epigenetic Aging
Toxics 2026
Open access · OA
Combined Effect of Per- and Polyfluoroalkyl Substances and Metals on Epigenetic Aging.
2026
Preprint